A. Chabanel

1.1k total citations
34 papers, 817 citations indexed

About

A. Chabanel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, A. Chabanel has authored 34 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in A. Chabanel's work include Blood properties and coagulation (17 papers), Erythrocyte Function and Pathophysiology (9 papers) and Lipid Membrane Structure and Behavior (6 papers). A. Chabanel is often cited by papers focused on Blood properties and coagulation (17 papers), Erythrocyte Function and Pathophysiology (9 papers) and Lipid Membrane Structure and Behavior (6 papers). A. Chabanel collaborates with scholars based in France, United States and Canada. A. Chabanel's co-authors include G. Coscas, A. Glacet–Bernard, F. Lelong, M Samama, Shu Chien, David Schachter, M Samama, K.L. Paul Sung, Maria Flamm and A Taccoen and has published in prestigious journals such as Blood, Biophysical Journal and Hypertension.

In The Last Decade

A. Chabanel

34 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Chabanel France 16 274 220 182 169 142 34 817
Siqi Li China 14 40 0.1× 62 0.3× 71 0.4× 21 0.1× 135 1.0× 64 591
Carolina Valdiviezo United States 14 8 0.0× 90 0.4× 69 0.4× 138 0.8× 173 1.2× 26 846
Robert Beetham United Kingdom 16 24 0.1× 63 0.3× 60 0.3× 32 0.2× 176 1.2× 37 747
Mano Swartz United States 11 354 1.3× 16 0.1× 26 0.1× 151 0.9× 171 1.2× 23 613
Elena Y. Senchenkova United States 13 10 0.0× 76 0.3× 55 0.3× 39 0.2× 244 1.7× 20 784
Martin M. Nentwich Germany 18 809 3.0× 42 0.2× 25 0.1× 412 2.4× 189 1.3× 52 1.2k
Bülent Mızrak Türkiye 15 41 0.1× 142 0.6× 59 0.3× 55 0.3× 49 0.3× 55 665
Mustafa Ünal Türkiye 19 499 1.8× 42 0.2× 60 0.3× 470 2.8× 214 1.5× 73 1.1k
Shigenori Yoshitake Japan 13 8 0.0× 73 0.3× 41 0.2× 54 0.3× 240 1.7× 47 733
Rachid Mechmèche Tunisia 15 9 0.0× 177 0.8× 39 0.2× 49 0.3× 88 0.6× 81 830

Countries citing papers authored by A. Chabanel

Since Specialization
Citations

This map shows the geographic impact of A. Chabanel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Chabanel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Chabanel more than expected).

Fields of papers citing papers by A. Chabanel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Chabanel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Chabanel. The network helps show where A. Chabanel may publish in the future.

Co-authorship network of co-authors of A. Chabanel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Chabanel. A scholar is included among the top collaborators of A. Chabanel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Chabanel. A. Chabanel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chabanel, A., Julie Léger, R. Tardivel, et al.. (2012). Plasma transfusion in liver transplantation: a randomized, double‐blind, multicenter clinical comparison of three virally secured plasmas. Transfusion. 53(6). 1335–1345. 25 indexed citations
2.
Nightingale, M. J., et al.. (2011). Eurobloodpack: a common European design for blood bag systems with integral leucodepletion filters. Vox Sanguinis. 101(3). 250–254. 3 indexed citations
3.
Bolzinger, Marie‐Alexandrine, et al.. (2010). Skin contamination by radiopharmaceuticals and decontamination strategies. International Journal of Pharmaceutics. 402(1-2). 44–49. 24 indexed citations
4.
Chabanel, A., et al.. (2008). National French observatory of the quality of blood components for transfusion. Transfusion Clinique et Biologique. 15(3). 85–90. 14 indexed citations
5.
Chabanel, A., et al.. (2007). Quality of leucoreduced red blood cell concentrates: 5 years of follow‐up in France. Vox Sanguinis. 94(1). 41–47. 17 indexed citations
6.
Chabanel, A., M. Massé, J Maurel, et al.. (2003). Quality assessment of seven types of fresh‐frozen plasma leucoreduced by specific plasma filtration. Vox Sanguinis. 84(4). 308–317. 18 indexed citations
7.
Chabanel, A., G. Andreu, Fabrice Carrat, & P Hervé. (2002). Quality control of leucoreduced cellular blood components in France. Vox Sanguinis. 82(2). 67–71. 11 indexed citations
8.
Glacet–Bernard, A., et al.. (1996). Prognostic Factors for Retinal Vein Occlusion. Ophthalmology. 103(4). 551–560. 171 indexed citations
9.
Zuccarelli, F, et al.. (1995). Increasing erythrocyte aggregability with the progressive grades of chronic venous insufficiency: importance and mechanisms.. PubMed. 36(4). 387–91. 11 indexed citations
10.
Glacet–Bernard, A., et al.. (1994). A Randomized, Double-Masked Study on the Treatment of Retinal Vein Occlusion With Troxerutin. American Journal of Ophthalmology. 118(4). 421–429. 67 indexed citations
11.
Vin, F., et al.. (1994). Double-Blind Trial of the Efficacy of Troxerutin in Chronic Venous Insufficiency. Phlebology The Journal of Venous Disease. 9(2). 71–76. 17 indexed citations
12.
Chabanel, A., et al.. (1994). Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post‐thrombotic treatment. British Journal of Haematology. 88(1). 174–179. 35 indexed citations
13.
Chabanel, A. & M Samama. (1994). Evaluation of a method to assess plasma viscosity: The falling ball viscometer. Clinical Hemorheology and Microcirculation. 14(3). 401–412. 1 indexed citations
14.
Chabanel, A., et al.. (1991). 35 Increase in erythrocyte deaggregation shear stress in hypertension. Journal of Hypertension. 9(9). 882–882. 7 indexed citations
15.
Chabanel, A., et al.. (1990). Increased red blood cell aggregation in retinal vein occlusion. British Journal of Haematology. 75(1). 127–131. 41 indexed citations
16.
Chabanel, A., et al.. (1989). Viscoelastic properties of red cell membrane in hereditary elliptocytosis. Blood. 73(2). 592–595. 17 indexed citations
17.
Reinhart, Walter H., et al.. (1987). Evaluation of a filter aspiration technique to determine membrane deformability.. PubMed. 110(4). 483–94. 4 indexed citations
18.
Freedman, John, et al.. (1985). Effect of complement on the viscoelastic properties of human erythrocyte membrane. British Journal of Haematology. 61(3). 455–466. 15 indexed citations
19.
Chabanel, A., et al.. (1983). Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophysical Journal. 44(2). 171–176. 126 indexed citations
20.
Winlove, C.P., et al.. (1982). Effects of particle size and perfusate composition on the uptake of colloidal gold by the rabbit thoracic aorta perfused in situ. Atherosclerosis. 44(1). 99–111. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026